Doctors at the Canadian Medical Association (CMA) are calling on the federal government to reconsider a proposed regulation to require pharmacists to obtain a prescription from a doctor or hospital first.
The regulation would require pharmacist’s to get a prescription before they can sell a product, such as a pill or injectable drug, from a pharmacy in Canada.
Pharmacists could also be charged for dispensing drugs if they do not have a prescription.
“What the proposed regulation would do is essentially allow pharmacy owners to take advantage of the fact that the government will be allowing them to sell to Canadians, regardless of what their qualifications are,” said Dr. Mark H. Pritchard, president of the CMA’s Canadian Branch.
“This is not the case.
We have an obligation to ensure that we are providing the highest quality medicine, and we need to do it in a way that is not undermining the health of Canadians.”
The CMA has also called on the government to remove the proposed requirements, which have been the subject of public consultation.
A statement released Thursday by the CBA, which represents Canada’s pharmacists, said the proposed regulations will not provide pharmacists with sufficient safeguards to protect the health and safety of Canadians.
“The proposed regulation has no meaningful effect on pharmacists who may sell drugs and who do not carry a prescription in their possession,” the statement read.
“It does not provide clear guidance on when a pharmacist is required to obtain authorization from a health care provider, and it does not require pharmacys to have an ongoing relationship with a health authority.”
“The pharmacists we represent understand that pharmacists are essential to our community, and the best pharmacists can do is do the best job they can to provide the best service to their patients.”
The proposed regulation does not address the issue of pharmacies selling to Canadians outside Canada.
“In particular, the proposed changes will adversely impact pharmacists in Ontario who are members of the Ontario Pharmacists’ Association. “
As the association’s executive director, we are concerned that the proposed regulatory change will negatively impact our members,” said the statement.
“In particular, the proposed changes will adversely impact pharmacists in Ontario who are members of the Ontario Pharmacists’ Association.
The CFA is currently reviewing its position regarding this issue.”